Correlation Between Tarsus Pharmaceuticals and Globalfoundries

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Globalfoundries at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Globalfoundries into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Globalfoundries, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Globalfoundries and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Globalfoundries. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Globalfoundries.

Diversification Opportunities for Tarsus Pharmaceuticals and Globalfoundries

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Tarsus and Globalfoundries is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Globalfoundries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Globalfoundries and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Globalfoundries. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Globalfoundries has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Globalfoundries go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Globalfoundries

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.79 times more return on investment than Globalfoundries. However, Tarsus Pharmaceuticals is 1.26 times less risky than Globalfoundries. It trades about 0.3 of its potential returns per unit of risk. Globalfoundries is currently generating about 0.07 per unit of risk. If you would invest  3,303  in Tarsus Pharmaceuticals on September 24, 2024 and sell it today you would earn a total of  2,151  from holding Tarsus Pharmaceuticals or generate 65.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Globalfoundries

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Globalfoundries 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Globalfoundries are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady technical and fundamental indicators, Globalfoundries unveiled solid returns over the last few months and may actually be approaching a breakup point.

Tarsus Pharmaceuticals and Globalfoundries Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Globalfoundries

The main advantage of trading using opposite Tarsus Pharmaceuticals and Globalfoundries positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Globalfoundries can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Globalfoundries will offset losses from the drop in Globalfoundries' long position.
The idea behind Tarsus Pharmaceuticals and Globalfoundries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets